CMS to cover stool DNA test Cologuard

CMS has issued its final National Coverage Determination for the colorectal cancer stool DNA test Cologuard, developed by Exact Sciences.

Advertisement

CMS will cover the test for Medicare Part B beneficiaries once every three years. Those eligible for coverage are:

    •    50 years to 85 years old
    •    Asymptomatic
    •    At average risk for colorectal cancer

Coverage goes into effect today, but CMS has yet to release its preliminary pricing decision.

More articles on gastroenterology:
10 statistics on gastroenterologist salary by subspecialty
Gastroenterologists & ACOs: In or out?
3 gastroenterologists & internal medicine physicians in the headlines

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.